Szwergold

Szwergold, B.S., Howell, S., and Beisswenger, P.J. (2001) Human fructosamine-3-kinase purification, sequencing, substrate specificity, and evidence of activity in vivo. Diabetes 50, 2139-2147. 

There are a number of other nuclei which can be detected by NMR in vivo. However, these have been used to a much lesser extent (see Szwergold, 1992, and references cited therein). 

B. S. Szwergold, K. Taylor, S. Lai, B. Su, F. Kappler, and T. R. Brown, Identification of a novel protein kinase activity specific for Amadori adducts on glycated proteins, Diabetes, 1997, 46, 108A. 

B. S. Szwergold, S. K. Howell, and P. J. Beisswenger, Nonenzymatic glycation/enzy-matic deglycation A novel hypothesis on the etiology of diabetic complications, in G, 2002, 143-152. 

J. R. Conner, P. J. Beisswenger, and B. S. Szwergold, The expression of the genes for finctosamine-3-kinase and fhictosamine-3-kinase-related protein appears to be constitutive and unaffected by environmental signals, Biochem. Biophys. Res. Commun., 323 (2004) 932—936. 

B. S. Szwergold, Fructosamine-6-phosphates are deglycated by phosphorylation to fiiictosaniine-3,6-bisphosphates catalyzed by fructosamine-3-kinase (FN3K) and/or fructosamine-3-kinase-related-protein (FN3KRP), Med. Hypotheses, 68 (2007) 37 5. 

Szwergold BS (1992) NMR spectroscopy of cells. Annual Review of Physiology 54 775-798. 

---